Pine Valley Investments Ltd Liability Co Has $722,000 Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Pine Valley Investments Ltd Liability Co lessened its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 26.0% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,956 shares of the financial services provider’s stock after selling 1,745 shares during the quarter. Pine Valley Investments Ltd Liability Co’s holdings in iShares Biotechnology ETF were worth $722,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Brookstone Capital Management grew its position in iShares Biotechnology ETF by 203.5% in the second quarter. Brookstone Capital Management now owns 20,117 shares of the financial services provider’s stock valued at $2,944,000 after acquiring an additional 13,488 shares during the last quarter. Hoylecohen LLC bought a new stake in shares of iShares Biotechnology ETF during the 2nd quarter valued at approximately $368,000. Raymond James & Associates grew its holdings in shares of iShares Biotechnology ETF by 4.4% during the 2nd quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock valued at $26,047,000 after purchasing an additional 7,931 shares during the last quarter. Williams Financial LLC acquired a new position in iShares Biotechnology ETF during the 2nd quarter worth approximately $867,000. Finally, KFG Wealth Management LLC bought a new position in iShares Biotechnology ETF in the 2nd quarter valued at approximately $214,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of iShares Biotechnology ETF stock opened at $136.61 on Friday. The company’s 50 day moving average price is $141.84 and its two-hundred day moving average price is $142.25. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were issued a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.